4//SEC Filing
Hannah Brendan 4
Accession 0001415889-24-015533
CIK 0001662774other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 2:37 PM ET
Size
7.1 KB
Accession
0001415889-24-015533
Insider Transaction Report
Form 4
Hannah Brendan
CBO, COO and CCO
Transactions
- Exercise/Conversion
Common Stock
2024-06-04$0.55/sh+56,061$30,834→ 257,616 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-06-04−56,061→ 47,439 totalExercise: $0.55Exp: 2032-03-27→ Common Stock (56,061 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001929422
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 2:37 PM ET
- Size
- 7.1 KB